TT-OAD2 is a non-peptide glucagon-like peptide-1 ( GLP-1 ) receptor agonist with an EC 50 of 5 nM. TT-OAD2 has the potential for diabetes treatment.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GCGR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.